Annual report [Section 13 and 15(d), not S-K Item 405]

Earnings Per Share (Tables)

v3.25.4
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data) Year Ended December 31,
2025 2024 2023
Numerator         
Net increase (decrease) in net assets resulting from operations $ 339,737  $ 262,966  $ 337,484 
Less: Total distributions declared (335,263) (312,244) (278,301)
Total Earnings (loss), net of total distributions 4,474  (49,278) 59,183 
        
Earnings (loss), net of distributions attributable to common shares 4,438  (49,278) 58,593 
Add: Distributions declared attributable to common shares 332,587  309,413  275,548 
Numerator for basic change in net assets per common share 337,025  260,135  334,141 
       Add: Income impact of assumed conversion of 2028 Convertible Notes
13,174  —  — 
Numerator for diluted change in net assets per common share $ 350,199  $ 260,135  $ 334,141 
        
Denominator         
Basic weighted average common shares outstanding 177,392  161,082  144,091 
Incremental shares from assumed conversion of 2028 Convertible Notes 10,859  —  — 
Common shares issuable 610  517  735 
Weighted average common shares outstanding assuming dilution 188,861  161,599  144,826 
Change in net assets per common share:
Basic $ 1.90  $ 1.61  $ 2.32 
Diluted $ 1.85  $ 1.61  $ 2.31 
Schedule of Number of Anti-diluted Shares As Calculated Based on Weighted Average Closing Price of Common Stock For the years ended December 31, 2025, 2024 and 2023, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
  Year Ended December 31,
Anti-dilutive Securities 2025 2024 2023
Unvested common stock options 1,324 1,105 1,496
Restricted stock units 4,357
Unvested restricted stock awards 917 298 30,028